| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Alpha Tau Medical Ltd.'s insiders have reduced their positions by a net 20,601 shares worth roughly $291K.
Classified under Biotechnology (Healthcare sector), DRTS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 93.1K | $277.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Levy Raphi | Chief Financial Officer | Sale+OE | 2,871 | $15.00 | $43,073.04 | -3.1% | |
| Aug 11, 2026 | Levy Raphi | Chief Financial Officer | Sale+OE | 17,730 | $14.00 | $248,276.74 | -16.4% | |
| Jul 6, 2026 | Levy Raphi | Chief Financial Officer | Sale+OE | 2,270 | $14.00 | $31,782.50 | -2.5% | |
| Jul 2, 2026 | Levy Raphi | Chief Financial Officer | Sale+OE | 17,873 | $13.00 | $232,397.26 | -16.5% | |
| Jul 1, 2026 | Levy Raphi | Chief Financial Officer | Sale+OE | 2,127 | $13.02 | $27,691.20 | -2.3% | |
| Jun 30, 2026 | Levy Raphi | Chief Financial Officer | Sell | 20,000 | $12.00 | $240,044.00 | -18.2% | |
| Jun 25, 2026 | Levy Raphi | Chief Financial Officer | Sell | 20,000 | $11.00 | $220,004.00 | -15.4% | |
| Jun 23, 2026 | Levy Raphi | Chief Financial Officer | Sell | 17,500 | $9.55 | $167,051.00 | -11.8% | |
| Jun 3, 2026 | Levy Raphi | Chief Financial Officer | Sell | 32,500 | $10.83 | $352,115.25 | -18.0% |